Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
Short excerpt below. Click through to read at the original source.
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.